Want to see DHC full AI Analyst Report?
Revenue by Segment
How revenue is split across different business segments and property types, showing which areas drive the top line. Useful for spotting reliance on specific markets, tenants, or service lines and for assessing sensitivity to occupancy trends, payer mix, and contract or reimbursement changes.SHOP is the clear growth engine — steady, multi‑quarter expansion driven by rate increases and improving occupancy — while the historical Office Portfolio disappears in 2024 as revenues shift into a newly reported Medical Office & Life Science line. MO/LS spiked on reclassification then drifted lower, likely from lease‑timing and rollover noise despite strong leasing metrics and high occupancy; management flagged roughly 9% near‑term expirations. Small, seasonal 'Other' spikes recur. Management expects SHOP NOI momentum to continue and is focused on leverage reduction and accretive capital deployment.
Date | Other | SHOP | Medical Office & Life Science Portfolio |
|---|---|---|---|
Jun 30, 2026 | $7.35M | $317.92M | $40.12M |
Mar 31, 2026 | $7.35M | $317.23M | $41.90M |
Dec 31, 2025 | $8.37M | $323.41M | $47.79M |
Sep 30, 2025 | $7.12M | $333.39M | $48.20M |
Jun 30, 2025 | $7.11M | $327.55M | $48.06M |
Mar 31, 2025 | $8.79M | $328.31M | $49.76M |
Dec 31, 2024 | $12.17M | $315.74M | $51.72M |
Sep 30, 2024 | $8.73M | $312.00M | $52.90M |
Jun 30, 2024 | $8.31M | $308.52M | $54.55M |
Mar 31, 2024 | $8.50M | $308.13M | $54.15M |